For one of our clients, we are looking for pharmaceutical companies that are willing to expand and/or innovate their portfolio in Cough & Cold.
Our client holds a Marketing Authorization for two phytopharmaceutical cough syrups in 10 European countries, a pan European brand and a pipeline. They are looking for distributors or in-licensors to market these products.
Nowadays, the diversity in Cough & Cold OTC medicines is poor. The evolution to medicinal products with one single active ingredient and the ban of several cough & cold products with multiple active ingredients, resulted mainly in a broad offering of similar cough syrups with just a different label and brand. The PRAC review of codeine, ambroxol and bromhexine and local restrictions for these products further limited the diversity in the Cough & Cold OTC market.
So if you are you are interested in bringing innovation into the Cough & Cold OTC market with a portfolio of ‘green’, natural and high-quality medicinal cough syrups, please contact us at +32 16 891 600 or email@example.com. We will be happy to provide you with more information.